Abstract
Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), can develop various complications during the chronic remitting course. In the long-term course of the disease process, colorectal cancer (CRC) represents the most serious and life-threatening hazard. Evaluation of the incidence, risk factors, and confounding factors has been discussed, and surveillance methods have been established to lessen the burden on IBD patients. In this chapter, recent epidemiological trends and risk factors for CRC in IBD are discussed, and radiographic and endoscopic pictures of malignancies in UC and CD are presented.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Eaden J, Abrams KR, Mayberry JF, et al. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35.
Gilat T, Fireman Z, Grossman A, et al. Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology. 1988;94:870–7.
Lennard-Jones JE, Melville DM, Morson BC, et al. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut. 1990;31:800–6.
Winther KV, Jess T, Langholtz E, et al. Long-term risk of cancer in ulcerative colitis: a population based cohort study from Copenhagen county. Clin Gastroenterol Hepatol. 2004;2:1088–95.
Lakatos L, Mester G, Erdelyi Z, et al. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian Cohort of patients with ulcerative colitis: results of a population-based study. Inflamm Bowel Dis. 2006;12:205–11.
Rutter M, Saunders B, Wilkinson K, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006;130:1030–8.
Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut. 1988;29:206–17.
Higashi D, Futami K, Ishibashi Y, et al. Clinical course of colorectal cancer in patients with ulcerative colitis. Anticancer Res. 2011;31:2499–504.
Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007;133:1099–105.
Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451–9.
Rutter MD, Saunders BP, Wilkinson KH, et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc. 2004;60:334–9.
Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (updated from 2002). Gut. 2010;59:666–89.
Choi PM, Nugent FW, Schoetz DJ, et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology. 1993;105:418–24.
Lutgens MW, Oldenburg B, Siersema PD, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009;101:1671–5.
Matsumoto T, Iwao Y, Igarashi M, et al. Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. Inflamm Bowel Dis. 2008;14:259–64.
Blackstone MO, Riddell RH, Rogers BHG, et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981;80:366–74.
Rutter M, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53:256–60.
Matsumoto T, Nakamura S, Jo Y, et al. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol. 2003;98:1827–33.
Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large bowel cancer in Crohn’s disease with colonic involvement. Lancet. 1990;336:357–9.
Persson PG, Karlen P, Bernell O, et al. Crohn’s disease and cancer: a population based cohort study. Gastroenterology. 1994;107:1675–9.
Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology. 1993;105:1716–23.
Fireman Z, Grossman A, Lilos P, et al. Intestinal cancer in patients with Crohn’s disease. Scand J Gastroenterol. 1989;24:346–50.
Jess T, Winther KV, Munkholm P, et al. Intestinal and extra-intestinal cancer in Crohn’s disease: follow-up of a population-based cohort in Copenhagen county, Denmark. Aliment Pharmacol Ther. 2004;19:287–93.
Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35:1507–8.
Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther. 2006;23:1097–104.
Friedman S, Rubin PH, Bodian C, et al. Screening and surveillance colonoscopy in chronic Crohn’s colitis. Gastroenterology. 2001;120:820–6.
Friedman S, Rubin PH, Bodian C, et al. Screening and surveillance colonoscopy in chronic Crohn’s colitis: results of a surveillance program spanning 25 years. Clin Gastroenterol Hepatol. 2008;6:993–8.
Yano Y, Matsui T, Uno H, et al. Risks and clinical features of colorectal cancer complicating Crohn’s disease in Japanese patients. J Gastroenterol Hepatol. 2008;23:1683–8.
Yano Y, Matsui T, Hirai F, Okado Y, et al. Cancer risk in Japanese Crohn’s disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28:1300–5.
Nishimura T, Matsui T, Hirai F, et al. Radiographic diagnosis of ulcerative colitis associated neoplasia. Stomach Intestine 2008;43: 1281–92.
Higashi D, Futami K, Ishibashi Y, et al. Clinical course of colorectal cancer in patients with ulcerative colitis. Anticancer Res 2011;31:2499–504.
Higashi D, Futami K, Kojima D, et al. Cancer of the small intestine in patients with Crohn’s disease. Anticancer Res. 2013;33:2977–80.
Yao S, Iwashita A, Nishimura T, et al. Colo-rectal cancer complicated with Crohn’s disease. Stomach Intestine 2002;37:1047–58.
Futami K, Higashi D, Egawa Y et al. Intestinal cancer in patients with Crohn’s disease: Diagnosis, treatment and prognosis. Anticancer Res. 2013;33:2977–80.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Matsui, T. (2015). Malignancies: Colitic Cancer and Small Bowel Cancer (Intestinal Cancer) in IBD. In: Kim, W., Cheon, J. (eds) Atlas of Inflammatory Bowel Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39423-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-39423-2_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39422-5
Online ISBN: 978-3-642-39423-2
eBook Packages: MedicineMedicine (R0)